Strategies for receptor control of neurotransmitter release.
Nicholls
D G
DG
Department of Pharmacology, Ninewells Medical School, University of Dundee, United Kingdom.
D015761:4-Aminopyridine / Q000494:pharmacology; D000200:Action Potentials / Q000502:physiology; D000818:Animals; D015220:Calcium Channels / Q000502:physiology; D003515:Cycloleucine / Q000031:analogs & derivatives / Q000494:pharmacology; D004546:Elapid Venoms / Q000494:pharmacology; D005089:Exocytosis / Q000502:physiology*; D018698:Glutamic Acid / Q000378:metabolism*; D006706:Homeostasis; D008959:Models, Neurological; D018696:Neuroprotective Agents / Q000494:pharmacology; D009498:Neurotoxins / Q000494:pharmacology; D015221:Potassium Channels / Q000502:physiology; D011189:Potassium Chloride / Q000494:pharmacology; D011493:Protein Kinase C / Q000378:metabolism; D051381:Rats; D018094:Receptors, Metabotropic Glutamate / Q000187:drug effects / Q000502:physiology*; D018047:Receptors, Purinergic P1 / Q000502:physiology*; D013574:Synaptosomes / Q000502:physiology*
D015220:Calcium Channels; D004546:Elapid Venoms; D018696:Neuroprotective Agents; D009498:Neurotoxins; D015221:Potassium Channels; D018094:Receptors, Metabotropic Glutamate; D018047:Receptors, Purinergic P1; C108582:dendrotoxin I; D003515:Cycloleucine; C036361:1-amino-1,3-dicarboxycyclopentane; D018698:Glutamic Acid; D011189:Potassium Chloride; D015761:4-Aminopyridine; D011493:Protein Kinase C